Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin

AIMS/INTRODUCTION: To identify the effect of combination therapy with a dipeptidyl peptidase‐4 inhibitor and a sodium–glucose cotransporter 2 inhibitor compared with switching from a dipeptidyl peptidase‐4 inhibitor to a sodium–glucose cotransporter 2 inhibitor on improving the glucose variability i...

Descripción completa

Detalles Bibliográficos
Autores principales: Miya, Aika, Nakamura, Akinobu, Cho, Kyu Yong, Kawata, Shinichiro, Nomoto, Hiroshi, Nagai, So, Sugawara, Hajime, Taneda, Shinji, Tsuchida, Kazuhisa, Omori, Kazuno, Yokoyama, Hiroki, Takeuchi, Jun, Aoki, Shin, Kurihara, Yoshio, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354506/
https://www.ncbi.nlm.nih.gov/pubmed/33325645
http://dx.doi.org/10.1111/jdi.13479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354506/
https://www.ncbi.nlm.nih.gov/pubmed/33325645
http://dx.doi.org/10.1111/jdi.13479

Ejemplares similares